AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic
31. März 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 31, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) was recently appointed to the American Pain...